T 900607
Alternative Names: T 607; T900607; T900607-sodiumLatest Information Update: 23 Dec 2004
At a glance
- Originator Tularik
- Developer Amgen
- Class Antineoplastics; Sulfonamides
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Gastric cancer; Liver cancer; Non-Hodgkin's lymphoma; Oesophageal cancer; Ovarian cancer
Most Recent Events
- 23 Dec 2004 Discontinued - Phase-I for Cancer in Canada (IV)
- 23 Dec 2004 Discontinued - Phase-I for Cancer in United Kingdom (IV)
- 23 Dec 2004 Discontinued - Phase-II for Gastric cancer in USA (IV)